Angela Molaschi Pharmatex Italia Srl/Fisiopharma Srl

Angela Molaschi is Business Development Manager for Pharmatex Italia Srl and Fisiopharma Srl, two italian companies focused on development, production and commercialization of injectable drugs. In her current role Angela is responsible of the Business Development activities, including international customers management, new opportunities evaluation, commercial discussions and contracts, project management and technology transfer activities, CDMO business, in-licensing and out-licensing of products. Angela started her career in 2004 in Nerviano (MI), Italy, in a Pfizer production plant dedicated to injectables manufacturing, where she covered different roles in Six Sigma/Ops Excellence, Regulatory Compliance and Quality Assurance until 2008 when she started working in Technology Transfer. From 2008 to 2018 Angela acted as Technology Transfer and New Projects Leader taking care of introduction of new products and new technologies in Nerviano production plan, then acquired by Actavis/Teva and covering roles if increased responsibilities until becoming responsible of New Projects Introduction department. In 2018 Angela left Teva and joined an italian B2B company, NTC, as Technical Operations Manager, responsible of the outsourcing activities and CDMOs management. In 2020 Angela left NTC to join her current company.

Through the years Angela developed a great expertise in Technology Transfer and is leading training courses on this topic since several years.

She has a degree in "Pharmaceutical Biotechnology" at the University of Milan, Italy, Executive Master in Project Management at "Sole 24 Ore Business School", Milan, Italy, EMBA attendee at LIUC Business School, Castellanza (VA), Italy.

In addition to that Angela cooperates actively with PDA EU and PDA Italy for which she acted as President from 2017 to 2021.